City of Hope Medical Center: Carcinoma, Hepatocellular trials
The registry lists 12 Carcinoma, Hepatocellular studies with City of Hope Medical Center as lead sponsor. 4 are open to participants now and 2 have results posted.
Phase 1 4Phase 2 1No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing PancreatectomyNot yet recruitingNCT07608458Not applicable
- Project for Multi-Omics-Based Early Detection of Hepatocellular Carcinoma (PROMETHEA Study)RecruitingNCT07265271
- A Noninvasive and Screening miRNA Signature for Gastrointestinal CancerRecruitingNCT07224750
- An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver CancerRecruitingNCT06342414
- A Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular CancerTerminatedNCT03026803Phase 2Results posted
- Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive CancerActive, not recruitingNCT02293954Not applicableResults posted
- Durvalumab and Tremelimumab After Radioembolization for the Treatment of Unresectable, Locally Advanced Liver CancerActive, not recruitingNCT04605731Phase 1
- IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver CancerActive, not recruitingNCT03655002Phase 1
- Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family CaregiversCompletedNCT03267524Not applicable
- Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing SurgeryCompletedNCT02511821Not applicable
- Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior TherapyActive, not recruitingNCT02432963Phase 1
- Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver CancerCompletedNCT01666756Phase 1